Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study

por Ullrich, T., Arsov, C., Quentin, M., Mones, F., Westphalen, A. C., Mally, D., Hiester, A., Albers, P., Antoch, G., Schimmöller, L.
Publicado 2020

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy

por Klingebiel, M, Arsov, C, Ullrich, T, Quentin, M, Al-Monajjed, R, Mally, D, Sawicki, LM, Hiester, A, Esposito, I, Albers, P, Antoch, G, Schimmöller, L
Publicado 2022

Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer

por Brandt, Maximilian Peter, Ruf, C., Dieckmann, K. P., Syring, I., Ruckes, C., Nestler, T., Schmelz, H. U., Dotzauer, R., Hiester, A., Albers, P., Nettersheim, D., Bolenz, C., Loosen, S. H., Heidenreich, A., Pfister, D., Haferkamp, A., Zengerling, F., Paffenholz, P.
Publicado 2021